Alternative delivery systems for antiviral nucleosides and antisense oligonucleotides to the brain.
Levy
R M
RM
Department of Surgery (Neurosurgery), Northwestern University Medical School, Chicago, Illinois 60611, USA.
Ward
S
S
Schalgeter
K
K
Groothuis
D
D
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001921:Brain / Q000378:metabolism*; D002250:Carbon Radioisotopes; D002421:Caudate Nucleus / Q000378:metabolism; D002552:Cerebral Ventricles / Q000378:metabolism; D003561:Cytarabine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004337:Drug Carriers; D007839:Functional Laterality; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral; D051379:Mice; D008815:Mice, Inbred Strains; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage* / Q000493:pharmacokinetics; D009928:Organ Specificity; D051381:Rats; D017207:Rats, Sprague-Dawley; D013462:Sulfur Radioisotopes; D013873:Thionucleotides; D015215:Zidovudine / Q000008:administration & dosage* / Q000493:pharmacokinetics
D000998:Antiviral Agents; D002250:Carbon Radioisotopes; D004337:Drug Carriers; D016376:Oligonucleotides, Antisense; D013462:Sulfur Radioisotopes; D013873:Thionucleotides; D003561:Cytarabine; D015215:Zidovudine